Treatment options in renal cell carcinoma: past, present and future-Reference-Cited by-同舟云学术

Treatment options in renal cell carcinoma: past, present and future

Published:2007-09 Issue: Volume:18 Page:x25-x31
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Oudard S.,George D.,Medioni J.,Motzer R.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/18/suppl_10/x25/6672875/mdm411.pdf

Reference49 articles.

1. Global cancer statistics, 2002;Parkin;CA Cancer J Clin,2005

2. US National Institutes of Health. Surveillance, Epidemiology and End Results (SEER) Cancer Statistics Review. Kidney and Renal Pelvis Cancer. 5-year Relative Survival Rates, 1996–2002; http://seer.cancer.gov/cgi-bin/csr/1975_2003/search.pl#results (September 2006, date last accessed).

3. Cancer statistics, 2006;Jemal;CA Cancer J Clin,2006

4. Novel approaches in the therapy of metastatic renal cell carcinoma;Lam;World J Urol,2005

5. Renal-cell carcinoma;Motzer;N Engl J Med,1996

Cited by 58 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comprehensive analysis of LAMC1 expression and prognostic value in kidney renal papillary cell carcinoma and clear cell carcinoma;Frontiers in Molecular Biosciences;2022-09-16

2. CircME1 promotes aerobic glycolysis and sunitinib resistance of clear cell renal cell carcinoma through cis-regulation of ME1;Oncogene;2022-07-07

3. Real-World Metastatic Renal Cell Carcinoma Treatment Patterns and Clinical Outcomes in The Netherlands;Frontiers in Pharmacology;2022-03-23

4. Positive feedback regulation of lncRNA PVT1 and HIF2α contributes to clear cell renal cell carcinoma tumorigenesis and metastasis;Oncogene;2021-07-28

5. Androgen receptor modulates metastatic routes of VHL wild-type clear cell renal cell carcinoma in an oxygen-dependent manner;Oncogene;2020-09-17